KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organon (OGN) EBITDA Margin (2020 - 2025)

Organon (OGN) has 6 years of EBITDA Margin data on record, last reported at 13.93% in Q4 2025.

  • For Q4 2025, EBITDA Margin fell 416.0% year-over-year to 13.93%; the TTM value through Dec 2025 reached 18.19%, up 795.0%, while the annual FY2025 figure was 18.19%, 1556.0% up from the prior year.
  • EBITDA Margin reached 13.93% in Q4 2025 per OGN's latest filing, down from 22.35% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 55.77% in Q4 2021 and bottomed at 36.23% in Q4 2023.
  • Average EBITDA Margin over 5 years is 1.26%, with a median of 3.17% recorded in 2022.
  • Peak YoY movement for EBITDA Margin: tumbled -8830bps in 2022, then soared 6100bps in 2024.
  • A 5-year view of EBITDA Margin shows it stood at 55.77% in 2021, then crashed by -158bps to 32.53% in 2022, then dropped by -11bps to 36.23% in 2023, then surged by 150bps to 18.09% in 2024, then decreased by -23bps to 13.93% in 2025.
  • Per Business Quant database, its latest 3 readings for EBITDA Margin were 13.93% in Q4 2025, 22.35% in Q3 2025, and 20.33% in Q2 2025.